<DOC>
	<DOCNO>NCT01845441</DOCNO>
	<brief_summary>Dexmedetomidine unique sedative medication able provide sedation without cause respiratory depression maintain neurological function . Patients acute ischemic stroke need undergo endovascular therapy require constant assessment neurological status prior , interventional procedure . In study investigator compare efficacy Dexmedetomidine standard sedative medication provide optimal sedative effect maintain neurological function .</brief_summary>
	<brief_title>Use Dexmedetomidine Acute Stroke Cerebral Vasospasm Interventions</brief_title>
	<detailed_description>Precedex unique FDA-approved intravenous medication conscious sedation allow `` arousable '' sedation , particularly appeal use patient compromise neurologic function . While Precedex show equivalent , superior , conventional sedation procedural setting , yet evaluate set endovascular treatment acute stroke . This set particularly ripe evaluation , currently controversy best method management patient sedation light auxiliary need preserve neurologic function . In order evaluate benefit Precedex setting , must compare usual standard care . Through investigator double blind randomized trial , investigator obtain information comparison two arm , one receiving Precedex usual standard care investigator institution , achieve maintain pre-defined level conscious sedation , preserve baseline neurologic status . This assessment optimistically serve basis future large-scale study ultimately establishment Precedex first-line sedative management acute stroke cerebral vasospasm patient undergo endovascular intervention .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients acute ischemic stroke require endovascular intervention mNIHSS score obtain Patients cerebral vasospasm suspiciousness without subarachnoid hemorrhage mNIHSS score obtain . History severe hepatic disease severe renal disease ( GFR &lt; 20 ) . Hemodynamic instability . Pregnancy . Known allergy study drug . Evidence history cardiac electrophysiology instability include uncontrolled hemodynamically unstable complex atrial/ventricular arrhythmia conduction block time evaluation exception atrial fibrillation , heart rate le 60 systolic blood pressure less 90 . Respiratory compromise require intubation . Any medical ( include history cardiac conduction block , major hepatic renal disease ) laboratory abnormality may increase risk associate trial participation drug administration may interfere interpretation trial result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Endovascular procedure</keyword>
	<keyword>Stroke</keyword>
	<keyword>Vasospasm , intracranial</keyword>
	<keyword>Conscious sedation</keyword>
</DOC>